Jan Holub

Title: Jan Holub: Innovator in Heterocyclic Derivatives

Introduction

Jan Holub is a prominent inventor based in Olomouc, Czech Republic. He has made significant contributions to the field of chemistry, particularly in the development of novel heterocyclic derivatives. His work focuses on compounds that have potential applications in various sectors, including pharmaceuticals and agriculture.

Latest Patents

Jan Holub holds 2 patents that showcase his innovative research. His latest patents include:

1. Novel heterocyclic derivatives based on N-substituted adenine, which possess anticancer, mitotic, immunosuppressive, and antisenescent properties for plant, animal, and human cells. This patent also covers methods of preparation, pharmaceutical compositions, cosmetic preparations, and growth regulators that utilize these derivatives as active compounds.

2. Heterocyclic derivatives based on N-substituted adenine, which include specific formulas where R2 is hydrogen, R6 is R6'-X, X is —NH—, and R6' is substituted phenyl or substituted benzyl. These derivatives also exhibit anticancer, mitotic, immunosuppressive, and antisenescent properties, along with methods of preparation and applications in pharmaceuticals, cosmetics, and agriculture.

Career Highlights

Jan Holub is affiliated with the Institute of Experimental Botany of the Czech Academy of Sciences. His research has led to advancements in the understanding and application of heterocyclic compounds, making him a valuable asset in the scientific community.

Collaborations

Throughout his career, Jan has collaborated with notable colleagues, including Karel Dolezal and Igor Popa. These partnerships have further enriched his research and contributed to the success of his projects.

Conclusion

Jan Holub is a distinguished inventor whose work in heterocyclic derivatives has the potential to impact various fields significantly. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and practical applications.